Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.

Adlhoch C, Manďáková Z, Ethelberg S, Epštein J, Rimhanen-Finne R, Figoni J, Baylis SA, Faber M, Mellou K, Murphy N, O'Gorman J, Tosti ME, Ciccaglione AR, Hofhuis A, Zaaijer H, Lange H, de Sousa R, Avellón A, Sundqvist L, Said B, Ijaz S.

J Clin Virol. 2019 Nov;120:63-67. doi: 10.1016/j.jcv.2019.09.005. Epub 2019 Sep 19.

PMID:
31590112
2.

Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing.

Baylis SA, Hanschmann KO, Matsubayashi K, Sakata H, Roque-Afonso AM, Kaiser M, Corman VM, Kamili S, Aggarwal R, Trehanpati N, Gärtner T, Thomson EC, Davis CA, da Silva Filipe A, Abdelrahman TT, Blümel J, Terao E; HEV collaborative study group.

J Clin Virol. 2019 Oct;119:60-67. doi: 10.1016/j.jcv.2019.05.006. Epub 2019 May 14.

3.

Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products.

Yue C, Teitz S, Miyabashi T, Boller K, Lewis-Ximenez LL, Baylis SA, Blümel J.

Viruses. 2019 Mar 7;11(3). pii: E234. doi: 10.3390/v11030234.

4.

Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex.

Henss L, Yue C, Kandler J, Faddy HM, Simmons G, Panning M, Lewis-Ximenez LL, Baylis SA, Schnierle BS.

Viruses. 2019 Jan 18;11(1). pii: E82. doi: 10.3390/v11010082.

5.

The influence of petroleum oil films on the feather structure of tropical and temperate seabird species.

Matcott J, Baylis S, Clarke RH.

Mar Pollut Bull. 2019 Jan;138:135-144. doi: 10.1016/j.marpolbul.2018.11.010. Epub 2018 Nov 22.

PMID:
30660254
6.

Impact of hepatitis E virus testing on the safety of blood components in Germany - results of a simulation study.

Kamp C, Blümel J, Baylis SA, Bekeredjian-Ding I, Chudy M, Heiden M, Henseler O, Keller-Stanislawski B, de Vos AS, Funk MB.

Vox Sang. 2018 Nov;113(8):811-813. doi: 10.1111/vox.12719. Epub 2018 Oct 14.

PMID:
30318777
7.

Standardization of Nucleic Acid Tests: the Approach of the World Health Organization.

Baylis SA, Wallace P, McCulloch E, Niesters HGM, Nübling CM.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e01056-18. doi: 10.1128/JCM.01056-18. Print 2019 Jan. Review.

8.

External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil.

Baylis SA, Blümel J.

Emerg Infect Dis. 2018 Oct;24(10):1966. doi: 10.3201/eid2410.180360. No abstract available.

9.

External Quality Assessment (EQA) for Molecular Diagnostics of Zika Virus: Experiences from an International EQA Programme, 2016⁻2018.

Donoso Mantke O, McCulloch E, Wallace PS, Yue C, Baylis SA, Niedrig M.

Viruses. 2018 Sep 13;10(9). pii: E491. doi: 10.3390/v10090491. Review.

10.

A World Health Organization Human Hepatitis E Virus Reference Strain Related to Similar Strains Isolated from Rabbits.

Kaiser M, Delaune D, Chazouillères O, Blümel J, Roque-Afonso AM, Baylis SA.

Genome Announc. 2018 Apr 19;6(16). pii: e00292-18. doi: 10.1128/genomeA.00292-18.

11.

Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland.

Grabarczyk P, Sulkowska E, Gdowska J, Kopacz A, Liszewski G, Kubicka-Russel D, Baylis SA, Corman VM, Noceń E, Piotrowski D, Antoniewicz-Papis J, Łętowska M.

Transfusion. 2018 May;58(5):1245-1253. doi: 10.1111/trf.14531. Epub 2018 Mar 1.

PMID:
29492976
12.

External Quality Assessment (EQA) of Molecular Detection of Zika Virus: Value of the 1st World Health Organization International Standard.

Baylis SA, McCulloch E, Wallace P, Donoso Mantke O, Niedrig M, Blümel J, Yue C, Nübling CM.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01997-17. doi: 10.1128/JCM.01997-17. Print 2018 Mar. No abstract available.

13.

Precision and accuracy of commonly used dental age estimation charts for the New Zealand population.

Baylis S, Bassed R.

Forensic Sci Int. 2017 Aug;277:223-228. doi: 10.1016/j.forsciint.2017.06.011. Epub 2017 Jun 19.

PMID:
28666175
14.

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples.

Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD, Gangavarapu K, Oliveira G, Robles-Sikisaka R, Rogers TF, Beutler NA, Burton DR, Lewis-Ximenez LL, de Jesus JG, Giovanetti M, Hill SC, Black A, Bedford T, Carroll MW, Nunes M, Alcantara LC Jr, Sabino EC, Baylis SA, Faria NR, Loose M, Simpson JT, Pybus OG, Andersen KG, Loman NJ.

Nat Protoc. 2017 Jun;12(6):1261-1276. doi: 10.1038/nprot.2017.066. Epub 2017 May 24.

15.

Establishment and cryptic transmission of Zika virus in Brazil and the Americas.

Faria NR, Quick J, Claro IM, Thézé J, de Jesus JG, Giovanetti M, Kraemer MUG, Hill SC, Black A, da Costa AC, Franco LC, Silva SP, Wu CH, Raghwani J, Cauchemez S, du Plessis L, Verotti MP, de Oliveira WK, Carmo EH, Coelho GE, Santelli ACFS, Vinhal LC, Henriques CM, Simpson JT, Loose M, Andersen KG, Grubaugh ND, Somasekar S, Chiu CY, Muñoz-Medina JE, Gonzalez-Bonilla CR, Arias CF, Lewis-Ximenez LL, Baylis SA, Chieppe AO, Aguiar SF, Fernandes CA, Lemos PS, Nascimento BLS, Monteiro HAO, Siqueira IC, de Queiroz MG, de Souza TR, Bezerra JF, Lemos MR, Pereira GF, Loudal D, Moura LC, Dhalia R, França RF, Magalhães T, Marques ET Jr, Jaenisch T, Wallau GL, de Lima MC, Nascimento V, de Cerqueira EM, de Lima MM, Mascarenhas DL, Neto JPM, Levin AS, Tozetto-Mendoza TR, Fonseca SN, Mendes-Correa MC, Milagres FP, Segurado A, Holmes EC, Rambaut A, Bedford T, Nunes MRT, Sabino EC, Alcantara LCJ, Loman NJ, Pybus OG.

Nature. 2017 Jun 15;546(7658):406-410. doi: 10.1038/nature22401. Epub 2017 May 24.

16.
17.

Harmonization of nucleic acid testing for Zika virus: development of the 1st World Health Organization International Standard.

Baylis SA, Hanschmann KO, Schnierle BS, Trösemeier JH, Blümel J; Zika Virus Collaborative Study Group.

Transfusion. 2017 Mar;57(3pt2):748-761. doi: 10.1111/trf.14026. Epub 2017 Feb 23.

PMID:
28229462
18.

Genome Sequence of a Genotype 2 Hepatitis E Virus World Health Organization Reference Strain.

Kaiser M, Kamili S, Hayden T, Blümel J, Baylis SA.

Genome Announc. 2017 Feb 16;5(7). pii: e01664-16. doi: 10.1128/genomeA.01664-16.

19.

Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal products.

Blümel J, Musso D, Teitz S, Miyabayashi T, Boller K, Schnierle BS, Baylis SA.

Transfusion. 2017 Mar;57(3pt2):790-796. doi: 10.1111/trf.13873. Epub 2016 Oct 12.

PMID:
27731495
20.

Genome Sequence of a Candidate World Health Organization Reference Strain of Zika Virus for Nucleic Acid Testing.

Trösemeier JH, Musso D, Blümel J, Thézé J, Pybus OG, Baylis SA.

Genome Announc. 2016 Sep 1;4(5). pii: e00917-16. doi: 10.1128/genomeA.00917-16.

21.

Hepatitis E viral loads in plasma pools for fractionation.

Baylis SA, Corman VM, Ong E, Linnen JM, Nübling CM, Blümel J.

Transfusion. 2016 Oct;56(10):2532-2537. doi: 10.1111/trf.13722. Epub 2016 Jul 24.

PMID:
27453197
22.

Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15.

Adlhoch C, Avellon A, Baylis SA, Ciccaglione AR, Couturier E, de Sousa R, Epštein J, Ethelberg S, Faber M, Fehér Á, Ijaz S, Lange H, Manďáková Z, Mellou K, Mozalevskis A, Rimhanen-Finne R, Rizzi V, Said B, Sundqvist L, Thornton L, Tosti ME, van Pelt W, Aspinall E, Domanovic D, Severi E, Takkinen J, Dalton HR.

J Clin Virol. 2016 Sep;82:9-16. doi: 10.1016/j.jcv.2016.06.010. Epub 2016 Jun 23.

23.

Viral nucleic acids in human plasma pools.

Zhang W, Li L, Deng X, Blümel J, Nübling CM, Hunfeld A, Baylis SA, Delwart E.

Transfusion. 2016 Sep;56(9):2248-55. doi: 10.1111/trf.13692. Epub 2016 Jun 16.

PMID:
27306718
24.

Precision wildlife monitoring using unmanned aerial vehicles.

Hodgson JC, Baylis SM, Mott R, Herrod A, Clarke RH.

Sci Rep. 2016 Mar 17;6:22574. doi: 10.1038/srep22574.

25.

Hepatitis E Virus.

Pauli G, Aepfelbacher M, Bauerfeind U, Blümel J, Burger R, Gärtner B, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Offergeld R, Schlenkrich U, Schottstedt V, Seitz R, Strobel J, Willkommen H, Baylis SA; German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’.

Transfus Med Hemother. 2015 Jul;42(4):247-65. doi: 10.1159/000431191. Epub 2015 Jun 1. No abstract available.

26.

Standardization of NAT for Blood-Borne Pathogens.

Baylis SA, Chudy M, Nübling CM.

Transfus Med Hemother. 2015 Jul;42(4):211-8. doi: 10.1159/000435872. Epub 2015 Jul 1. Review.

27.

World Health Organization International Standard To Harmonize Assays for Detection of Mycoplasma DNA.

Nübling CM, Baylis SA, Hanschmann KM, Montag-Lessing T, Chudy M, Kreß J, Ulrych U, Czurda S, Rosengarten R; Mycoplasma Collaborative Study Group.

Appl Environ Microbiol. 2015 Sep 1;81(17):5694-702. doi: 10.1128/AEM.01150-15. Epub 2015 Jun 12.

28.

Unusual serological response to hepatitis E virus in plasma donors consistent with re-infection.

Baylis SA, Crossan C, Corman VM, Blümel J, Scobie L, Dalton HR.

Vox Sang. 2015 Nov;109(4):406-9. doi: 10.1111/vox.12294. Epub 2015 May 29.

PMID:
26031310
29.

Genome sequences of parvovirus b19 reference strains.

Trösemeier JH, Branting A, Lukashov VV, Blümel J, Baylis SA.

Genome Announc. 2014 Oct 9;2(5). pii: e00830-14. doi: 10.1128/genomeA.00830-14.

30.

Guidelines for photography of cutaneous marks and injuries: a multi-professional perspective.

Evans S, Baylis S, Carabott R, Jones M, Kelson Z, Marsh N, Payne-James J, Ramadani J, Vanezis P, Kemp A.

J Vis Commun Med. 2014 May;37(1-2):3-12. doi: 10.3109/17453054.2014.911152.

PMID:
24848573
31.

Focussing on the future: survey results on the image capture of patterned cutaneous injuries.

Evans S, Baylis S, Carabott R, Jones M, Lawson Z, Marsh N, Payne-James J, Ramadani J, Vanezis P, Kemp A.

J Forensic Leg Med. 2014 May;24:7-11. doi: 10.1016/j.jflm.2014.02.007. Epub 2014 Feb 28.

PMID:
24794842
32.

Porcine circovirus (PCV) removal by Q sepharose fast flow chromatography.

Yang B, Wang H, Ho C, Lester P, Chen Q, Neske F, Baylis SA, Blümel J.

Biotechnol Prog. 2013 Nov-Dec;29(6):1464-71. doi: 10.1002/btpr.1804. Epub 2013 Sep 20.

33.

Studies on the inactivation of human parvovirus 4.

Baylis SA, Tuke PW, Miyagawa E, Blümel J.

Transfusion. 2013 Oct;53(10 Pt 2):2585-92. doi: 10.1111/trf.12372. Epub 2013 Aug 19.

PMID:
24032592
34.

World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA.

Baylis SA, Blümel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, Nübling CM, Hanschmann KM; HEV Collaborative Study Group.

Emerg Infect Dis. 2013 May;19(5):729-35. doi: 10.3201/eid1905.121845.

35.

Seroprevalence and incidence of hepatitis E virus infection in German blood donors.

Juhl D, Baylis SA, Blümel J, Görg S, Hennig H.

Transfusion. 2014 Jan;54(1):49-56. doi: 10.1111/trf.12121. Epub 2013 Feb 26.

PMID:
23441647
36.

Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.

Sakata H, Matsubayashi K, Ihara H, Sato S, Kato T, Wakisaka A, Tadokoro K, Yu MY, Baylis SA, Ikeda H, Takamoto S.

Transfusion. 2013 Oct;53(10 Pt 2):2556-66. doi: 10.1111/j.1537-2995.2012.03949.x. Epub 2012 Nov 12.

PMID:
23145866
37.

Quality of photographic images provided for injury interpretation: room for improvement?

Payne-James JJ, Hawkins C, Baylis S, Marsh NP.

Forensic Sci Med Pathol. 2012 Dec;8(4):447-50. doi: 10.1007/s12024-012-9325-2. Epub 2012 Mar 6.

PMID:
22392018
38.

Inactivation and neutralization of parvovirus B19 Genotype 3.

Blümel J, Rinckel LA, Lee DC, Roth NJ, Baylis SA.

Transfusion. 2012 Jul;52(7):1490-7. doi: 10.1111/j.1537-2995.2012.03573.x. Epub 2012 Feb 17.

PMID:
22339291
39.

Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States.

Baylis SA, Gärtner T, Nick S, Ovemyr J, Blümel J.

Vox Sang. 2012 Jul;103(1):89-90. doi: 10.1111/j.1423-0410.2011.01583.x. Epub 2012 Jan 6. No abstract available.

PMID:
22220775
40.

Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.

Baylis SA, Ma L, Padley DJ, Heath AB, Yu MW; Collaborative Study Group.

Vox Sang. 2012 Apr;102(3):204-11. doi: 10.1111/j.1423-0410.2011.01541.x. Epub 2011 Oct 12.

PMID:
21988191
41.

Widespread distribution of hepatitis E virus in plasma fractionation pools.

Baylis SA, Koc O, Nick S, Blümel J.

Vox Sang. 2012 Feb;102(2):182-3. doi: 10.1111/j.1423-0410.2011.01527.x. Epub 2011 Aug 1. No abstract available.

PMID:
21806631
42.

Regulatory expectations of validation/qualification of adventitious virus assays.

Baylis SA, Blümel J.

PDA J Pharm Sci Technol. 2010 Sep-Oct;64(5):486-91.

PMID:
21502057
43.

World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays.

Baylis SA, Heath AB; Collaborative Study Group.

Vox Sang. 2011 May;100(4):409-17. doi: 10.1111/j.1423-0410.2010.01434.x. Epub 2010 Dec 13.

PMID:
21488880
44.

Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance.

Baylis SA, Hanschmann KM, Blümel J, Nübling CM; HEV Collaborative Study Group.

J Clin Microbiol. 2011 Apr;49(4):1234-9. doi: 10.1128/JCM.02578-10. Epub 2011 Feb 9.

45.

Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.

Grabarczyk P, Kalińska A, Kara M, Wieczorek R, Ejduk A, Sulkowska E, Gołębiowska-Staroszczyk S, Matysiak M, Baylis SA, Brojer E.

J Med Virol. 2011 Jan;83(1):142-9. doi: 10.1002/jmv.21947.

PMID:
21108352
46.

Analysis of porcine circovirus type 1 detected in Rotarix vaccine.

Baylis SA, Finsterbusch T, Bannert N, Blümel J, Mankertz A.

Vaccine. 2011 Jan 17;29(4):690-7. doi: 10.1016/j.vaccine.2010.11.028. Epub 2010 Nov 18.

PMID:
21093497
47.

Absence of detection of novel human parvoviruses in German plasma donations.

Eis-Hübinger AM, Drexler JF, Reber U, Panning M, Drosten C, Weber-Schehl M, Hedges D, Baylis SA, Roth WK.

Transfusion. 2010 Jan;50(1):266-7. doi: 10.1111/j.1537-2995.2009.02433.x. No abstract available.

PMID:
20233349
48.

Hepatitis E virus and blood donors in Germany.

Baylis SA, Nick S, Blümel J, Micha Nübling C.

Vox Sang. 2010 Apr;98(3 Pt 2):479. doi: 10.1111/j.1423-0410.2009.01258.x. Epub 2010 Feb 2. No abstract available.

PMID:
20136793
49.

Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.

Baylis SA, Chudy M, Blümel J, Pisani G, Candotti D, José M, Heath AB.

Vox Sang. 2010 Apr;98(3 Pt 2):441-6. doi: 10.1111/j.1423-0410.2009.01288.x. Epub 2009 Dec 8.

PMID:
20003130
50.

Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA.

Wilkinson DE, Baylis SA, Padley D, Heath AB, Ferguson M, Pagliusi SR, Quint WG, Wheeler CM; Collaborative Study Group.

Int J Cancer. 2010 Jun 15;126(12):2969-83. doi: 10.1002/ijc.25039.

Supplemental Content

Loading ...
Support Center